Page last updated: 2024-08-21

benzoxazoles and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester

benzoxazoles has been researched along with 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J; Li, Z; Liu, F; Wang, X; Zhang, Z; Zhuang, X1

Other Studies

1 other study(ies) available for benzoxazoles and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester

ArticleYear
P-Glycoprotein (ABCB1) limits the brain distribution of YQA-14, a novel dopamine D3 receptor antagonist.
    Chemical & pharmaceutical bulletin, 2015, Volume: 63, Issue:7

    Topics: Acridines; Adenosine; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoxazoles; Blood-Brain Barrier; Brain; Caco-2 Cells; Dibenzocycloheptenes; Diketopiperazines; Dopamine Antagonists; Half-Life; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Permeability; Piperazines; Quinolines; ROC Curve; Temperature; Tetrahydroisoquinolines

2015